Fertility is now covered as a purchase, not a treatment

The register changed before the demand did

Three stories from three countries this week, all written in the same voice. Slate published a piece on a procedure many young women are weighing up, under a headline that says the quiet part out loud: the writer hopes they understand what they are actually buying. HealthDay reported that high fertility costs are pushing Americans abroad for IVF. The Irish Independent ran Dearbhail McDonald on the painful decision to have her frozen eggs destroyed in her late forties, set against what the paper calls Ireland’s growing fertility crisis.

None of that is clinical journalism. It is consumer journalism, and the difference matters to anyone running a clinic. Clinical coverage asks whether a technique works. Consumer coverage asks what the money bought, what the contract said, what happened when it did not work out and who was left holding the storage fees. That is the register your next patient will have read before she ever types your speciality into a phone.

Whether any of these procedures is a good idea for a given person is not a question for a marketing article, and it will not be answered here. The market fact is what concerns you: the public conversation about fertility has moved from the medicine to the transaction, and it moved without asking the sector’s permission.

An access review is a demand event

FemTech World reported that an NHS IVF access review has been launched in Scotland. Read it as an operations story rather than a policy one. A review of publicly funded access does nothing to your clinical work and a great deal to the queue outside your door — and clinics almost always find out about that late, because the change arrives as a slow drift in enquiries rather than as an announcement.

It does not matter much, for planning purposes, which way a review lands. Widen the criteria and part of the self-funding cohort waits for the public route instead. Tighten them, or lengthen the wait, and that cohort arrives in the private sector already angry about a decision that was never yours. Either way the private waiting room changes composition, and either way the patient shows up having spent weeks on eligibility questions.

Those questions are worth naming, because each one is a search: am I eligible, what is covered, how long is the wait, what happens if I am turned down, what does it cost if I go privately. Right now they are answered by news outlets, by patient forums and by strangers in comment threads. They are almost never answered by a clinic, even though the clinic is the only party in the conversation that actually knows.

Set beside that, the study reported by Qazinform — that global fertility may have fallen below replacement level for the first time — tells you the shape of the coverage to come. Every fertility story from here gets a demographic peg, which means the category is covered more often, in general-news outlets, by writers with no clinical brief at all. The Irish Times piece arguing that quality public childcare and dependable fathers are key to raising fertility rates is the same phenomenon: a fertility headline written from a social-affairs desk. More coverage means more searching, and searching is neutral. It goes to whoever wrote the page.

The patient is comparing across borders before she calls anyone

The HealthDay story deserves a second look, because Spain sits on the receiving end of it. If cost is pushing patients out of one country, they are landing somewhere, and they are choosing that somewhere from a laptop, months ahead, on whatever evidence they can read in their own language.

That patient is not comparing clinics. She is comparing systems — a public wait against a private price against a flight — and she is doing it before any clinic has been contacted. A centre that publishes only in Spanish, only for its own city, and only about the treatments it performs is not in that comparison at all. Not losing it. Absent from it.

What can be published is narrower than a marketing plan would like and wider than most clinics assume. Not success rates dressed up as promises, and not outcomes of any kind: healthcare advertising in Spain is regulated, and the regulation is right about this. What is publishable is everything administrative — what a cycle includes and excludes, what is paid and when, how many visits require physical presence, what documentation a patient arriving from abroad needs, what storage costs after the first year, what happens to stored material if treatment is discontinued. That is service information rather than persuasion, it carries no clinical claim, and it is precisely the ground the consumer press is currently occupying because nobody else will.

The picture stopped counting as evidence

Woman & Home reported Lisa Riley’s anger at AI-generated pictures purporting to reveal a pregnancy after IVF and fertility struggles, with a line worth writing down: this has to stop.

Treat it as a market fact rather than a celebrity item. The audience most exposed to fertility content is now primed to suspect that an emotive image is fabricated, and that suspicion does not politely stop at the clinic’s door. The stock photograph of a baby’s hand, the tearful embrace on a homepage, the generated warmth in a banner — all of it now carries a credibility cost it did not carry a year ago, in the one category where readers are most alert to being played.

Which lands, conveniently, where the Spanish rules already pointed. Emotive imagery and implied results were the risky ground anyway. Plain pages, named professionals with their registration numbers, verifiable facts and photographs of a building that actually exists are the boring option, and they are quietly becoming the persuasive one.

What I would do this week

Take the last ten first-appointment enquiries and mark which ones asked about price, waiting time or public cover before they asked anything clinical. Then put those same questions into a phone and see who answers them. If the eligibility question is answered by a newspaper and the cost question by a forum, the pages you are missing have already been specified for you.